Charlotte's Web (CWBHF) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue was $12.3M, up 1.1% year-over-year, marking the first YoY growth since 2021, driven by a 3.2% increase in product revenue, e-commerce gains, and omnichannel expansion.

• Net loss narrowed to $6.2M from $9.6M in Q1 2024, reflecting cost reductions and improved operating efficiency.

• SG&A expenses decreased 24.2% year-over-year, supporting improved cash flow and operating efficiency.

• Terminated MLB Promotional Rights Agreement, waiving over $18M in future payments and improving future cash flow.

• FDA cleared DeFloria joint venture for Phase 2 clinical trials, opening potential new revenue streams.

Financial highlights

• Revenue: $12.3M in Q1 2025 vs. $12.1M in Q1 2024 (+1.1%).

• Gross profit: $6.2M (gross margin 50.8%) vs. $6.9M (57.0%) in Q1 2024.

• Operating loss: $5.3M–$5.4M vs. $8.4M in Q1 2024.

• Net loss: $6.2M ($0.04/share) vs. $9.6M ($0.06/share) in Q1 2024.

• Cash and cash equivalents: $19.4M as of March 31, 2025.

Outlook and guidance

• Management expects further SG&A reductions and improved operational efficiency in 2025.

• Sufficient liquidity is anticipated for the next 12 months, with a focus on reducing negative cash flows.

• Expects gross margin to remain in the low 50% range, aided by in-house manufacturing.

• Whole Foods Market rollout in over 400 stores set for June 2025, expected to strengthen retail presence.

• Ongoing product innovation and omnichannel expansion to drive growth.